Altimmune, Inc. (ALT)
4.18
+0.17
(+4.24%)
USD |
NASDAQ |
Jan 14, 16:00
4.175
0.00 (0.00%)
After-Hours: 20:00
Altimmune SG&A Expense (TTM): 22.68M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Viking Therapeutics, Inc. | 52.36M |
| CorMedix, Inc. | 75.56M |
| Seres Therapeutics, Inc. | 44.08M |
| Rhythm Pharmaceuticals, Inc. | 175.59M |
| Terns Pharmaceuticals, Inc. | 31.48M |